C ritical illnesses, stress, and surgery place increased demands on the body's nutritional requirements. These conditions promote a catabolic state and negative nitrogen balance. Prolonged bed rest and inactivity, per se, produce a negative nitrogen balance in healthy individuals (1) , and this effect is accentuated by exogenous steroids (2) . Thus, a hypermetabolic state, like in critical illness, trauma, or sepsis, in concert with bed rest and inactivity form a suitable environment for the occurrence of malnutrition.
Nutritional problems are common in hospitalized patients with the incidence varying depending on the population screened and the type of screening tool used. In a prospective study of 995 consecutive patients in Switzerland, malnutrition, defined by the authors as a body mass index (BMI) of Ͻ20 kg/m 2 , was observed in 17.3% (3) . In an Australian study, the incidence of malnutrition, assessed by subjective global assessment, was 36% in a cohort of 819 patients (4) . Patients identified as malnourished using BMI criteria, or nutritionally depleted by subjective global assessment, tend to stay longer in the hospital with increased costs of care (4 -6) and higher mortality (4) . Nutritional supplementation affords the opportunity of slowing down or stopping the catabolic process, restoring nitrogen balance, and preventing malnutrition.
Total parenteral nutrition (PN) was popular in the 1970s and 1980s (7) when it was used indiscriminately to counteract the metabolic problems associated with illnesses. However, within the paradigm of evidence-based medicine, a significant benefit of total PN has not been demonstrated. Heyland et al. (8) , evaluating 26 randomized, controlled trials (RCTs) involving 2,211 patients, compared the use of PN with standard care (usual oral diet plus intravenous fluids) in patients undergoing surgery. The results of this metaanalysis, reported as risk ratio (RR), suggested no mortality benefit with PN (RR, 1.03; 95% confidence interval [CI] , 0.81-1.31). There was a trend to a reduction in complication rates with PN (RR, 0.84; 95% CI, 0.64 -1.09), with significant benefits in malnourished patients (RR, 0.52; 95% CI, 0.30 -0.91).
Enteral nutrition (EN), on the other hand, has been advocated as a means of reducing mucosal atrophy and increased intestinal permeability with consequent reduction in the incidence of gut translocation and septic complications. Moreover, EN is popular because it is cheaper, more physiological, and probably safer. However, as pointed out in a recent editorial, this paradigm has not been substantiated (9) . Systematic review of published articles (10) and a metaanalysis (11) 
MATERIALS AND METHODS

Selection of Trials
RCTs comparing early EN and PN were considered for inclusion. Early EN or PN was defined as the institution of supplemental nutrition within 96 hours of hospitalization, intensive-care (ICU) admission, or surgery. Only trials reporting hospital mortality and/or complications or hospital length of stay (LOS) were included. Studies reporting only physiological or biochemical end points (amino acid turnover, nitrogen balance, cytokine levels, liver chemistry) and those treated with immunonutrition (arginine, nucleotides, omega-3 fatty acids) or glutamine were excluded. NonEnglish articles were also excluded.
Search Strategy
A computerized literature search was performed using National Library of Medicine's Entrez PubMed and OVID Medline for the period 1966 -2002. The search was restricted to studies on adult human population using the search terms: nutrition, enteral, parenteral, and controlled trials. Abstracts of trials generated by electronic search were reviewed and trials comparing EN and PN were retrieved for detailed evaluation. A manual hand-search was also undertaken for the period 1980 cles. Personal correspondence with authors was not sought. Identified studies were categorized as medical (e.g., inflammatory bowel disease, sepsis, pancreatitis), surgical (postoperative), or trauma.
Quality assessment on the selected studies was performed in an unblinded fashion by the three investigators on mode of randomization, definition of inclusion/exclusion criteria, reporting of complications, cointerventions, follow-up details, and intention-to-treat analysis. Quality scores were not derived.
Data Abstraction
Two investigators (JVP, JLM) abstracted data using standardized data collection forms. The extracted variables were predefined, and differences in data abstraction were settled by consensus.
Outcome Measures
The primary outcome assessed was mortality. Hospital and ICU mortality were collected. Secondary outcomes included: All complications were recorded as number of patients experiencing complications.
Statistical Methods
The effect of nutrition type on mortality and complication rates was expressed with 95% CI and p values as risk difference (RD) and hospital and ICU LOS as mean weighted difference (MWD days). For continuous variables (LOS), pooled estimates were only available if mean and standard deviation (SD) were reported. Analysis was performed with Stata (release 8; College Station, TX) using the METAN program (12) . Although treatment effect was assessed using both the methods of Mantel Haenszel (fixed-effects) and DerSimonian and Laird (random-effects), only the latter was reported because of heterogeneity of treatment effects.
Heterogeneity of treatment effects was assessed as 1) the extent, diagnosed by means of the Q statistic, considered significant at p Յ .1 (13, 14) ; and 2) the impact (on the variation of pooled treatment effect) by means of the I 2 measure, in which an I 2 of Ͻ30% indicates mild heterogeneity, 30% to 50% moderate, and substantially Ͼ50%, severe heterogeneity (14) .
Heterogeneity of treatment effects was further explored by: 1) sensitivity analysiscategorization of the study cohort into three primary groups (medical, surgical, or trauma) to assess if differences in outcome was an effect of patient group; and 2) metaanalytic regression (15, 16) using predefined confounders-age, admission albumin, and time to initiate treatment, considered as continuous variables, to ascertain if these factors affected outcomes.
Publication bias was assessed using the funnel plot, the rank correlation test of Begg, the regression-based test of Egger (17), and the nonparametric "trim and fill" method of Duval and Tweedie (18) . This method, a rankbased iterative data augmentation technique, formalizes the use of funnel plots, estimates the potential number and outcomes of missing studies, and adjusts the metaanalysis to incorporate the theoretical missing studies. A cumulative metaanalysis was also performed (19) to study possible time trends in treatment effects.
RESULTS
Preliminary search identified 3289 randomized trials on nutrition in an adult population. A single investigator reviewed abstracts of the 428 enteral and 618 parenteral nutrition articles. Of these, 105 articles were retrieved for further evaluation by the three investigators. Eighty-two articles were excluded (Table 1) . Twenty-three RCTs comparing early EN versus early PN were included. An additional seven studies were identified through hand-search and review of other articles. Studies were categorized into groups as medical (ten studies), surgical (11 studies), or trauma (nine studies) as well as based on etiology (Table 1) . Eleven studies included patients with malignant processes. The study cohort consisted of 30 studies (Table 2 ) from 1980 to 2002 that compared early EN with PN (20 -49) .
The EN and PN groups were matched for age, sex, time to initiate treatment, albumin levels at entry, and duration of nutritional supplementation. EN and PN were administered in all the studies in an unblinded fashion. Average daily caloric intakes were significantly lower (p ϭ .03, paired Student's t-test) and dropout rates significantly higher (p ϭ .001, Fisher exact) in the EN group (Table 3) .
Mortality
Only hospital mortality data were available and analyzed. ICU mortality was not reported in the studies. There was no differential treatment effect ( Fig. 1 ) of nutritional supplementation type on hospital morality on the study cohort as a whole as well as the individual subgroups (Table 4) . Heterogeneity was not observed.
Length of Stay
Hospital LOS (available as mean Ϯ SD in only 12 studies) was significantly reduced (p ϭ .004; MWD, 1.2 days; 95% CI; 0.38 -2.03; heterogeneity p ϭ .02; I 2 51%) in patients receiving EN (Fig. 2) . Subgroups were not analyzed because of small numbers. ICU LOS (four studies, 133 patients) was also significantly less with EN (p ϭ .008; MWD, 1.4 days; 95% CI, 0.37-2.4; heterogeneity p ϭ .05; I 2 61%).
Complications
The reporting of complications was variable, with complications reported both as number of episodes or as number of patients experiencing complications. Analysis was performed in those studies reporting the number of patients experiencing complications. Studies reporting complication rates in only one treatment arm were not considered.
Twenty-four studies reported infective complications. PN was associated with a significant increase in the incidence of infections (RD, 7.9%; p ϭ .001) overall (Fig. 3) as well as across all subgroups (Table 4) . Specifically, on post-hoc analysis, PN was shown to be associated with a significant increase in catheter-related bloodstream infections (RD, 3.5%; p ϭ .003; 95% CI, 1.2-5.8). There was no increase in pneumonias with EN (RD, 1.6%; p ϭ .24; 95% CI, Ϫ1.0 to 4.2).
Noninfective complications, documented in 15 studies, were significantly increased (RD, 4.9%; p ϭ .04) with PN (Fig. 4) . This effect, however, was significant only in the medical group (Table 4) ; heterogeneity of treatment effects was not observed.
Technical complications were mentioned in 23 studies. However, only 17 studies reported technical complications in both treatment arms. There was no difference in the incidence of technical complications between EN and PN. The medical group had a significant increase (RD, 9.4%; p ϭ .006) in technical complications with PN (Table 4) , but of note, heterogeneity was not observed. Significant heterogeneity was observed across other groups.
Diarrhea, although reported in 16 studies, was recorded in both treatment arms in only 11 studies. Overall, there was a significant increase in the incidence of diarrhea (RD, 8.7%; p ϭ .001) with EN. In the subgroups, diarrhea occurred more frequently with EN in the surgical and trauma groups (Table 4) . Heterogeneity was not observed.
Publication Bias
The Egger's test (p ϭ .89) and Begg's test (p ϭ .9) did not suggest publication bias. The trim and fill method (18) suggested one missing study; however, overall mortality estimates remained unchanged.
Metaanalytic Regression Analysis
Metaanalytic regression analysis (19) was performed to assess the (potential) effect of predefined covariates on the treatment effect (expressed as log odds ratio). Univariate analysis was used as the requirement for complete data on all cases for a multivariate model resulted in the sample size being too small for meaningful estimation. No modification of treatment effect was demonstrated.
Cumulative Metaanalysis
Cumulative metaanalysis did not show any change in the point estimates with time, although there was, not surprisingly, a narrowing of the confidence intervals with the addition of the more recently published articles.
DISCUSSION
Nutritional problems are commonly encountered in hospitalized patients, and interventions that could improve nutrition and potentially alter the course in the hospital are worthy of consideration. Aspects of nutrition such as time of initiation of nutrition support, the mode of nutritional supplementation, and the type of nutrients used have been the subject of numerous RCTs and systematic reviews.
Looking at the spectrum of nutrition trials, the lack of effect of nutrition on mortality is almost universal. Heyland et al. (8) , comparing PN with standard care, Marik and Zaloga (50), evaluating early EN compared with late/delayed EN, and Braunschweig et al. (11) , comparing two types of EN with PN, did not demonstrate a mortality benefit. The current metaanalysis, which focuses on early EN versus early PN, again did not show a mortality benefit of one over the other. Heterogeneity was not observed.
With secondary outcomes, however, a favorable effect of EN on complication rates and hospital and ICU LOS was observed. The significant reduction in hospital LOS observed with early EN (1.2 days) in the current metaanalysis, however, needs to be interpreted with caution given missing data (63%) and the moderate impact of heterogeneity Again, with only a small fraction of studies (13%) reporting ICU LOS in this metaanalysis, the significance of this result is debatable.
Early EN has been associated with lower infection rates compared with PN in the current metaanalysis as well as in previous analyses that compared early EN with late EN (50) and EN with PN/ standard care (11) . Heterogeneity has been consistently observed (11, 50 ). In the current study, the impact of heterogeneity (I 2 ), when considering all studies, was assessed as minimal to modest and was shown to be substantial only in the medical subgroup (Table 4 ). The reasons for heterogeneity in the medical group (n ϭ 8), although not immediately appar- Comp, noninfective complication; T-IT, time to initiate treatment (enteral or parenteral nutrition); IBD, inflammatory bowel disease; Y, where criteria was defined; N, where criteria not defined; RA, randomly allocated/randomly assigned; NA, not available; Yes, data available in the study; Ca, cancer; RND, randomized, but mode of randomization not defined or mentioned; RNB, randomization using random numbers; CRT, computer-generated random table; RS, randomization sequence; GIT, gastrointestinal tract surgery; RNE, randomized, numbered envelopes; RHN, randomization using hospital numbers; RDB, randomization using date of birth.
inflammatory bowel disease (n ϭ 4) and pancreatitis (n ϭ 3). In the former, more patients in the PN group required surgery and in the latter more patients treated with PN developed MOF. The reason for this finding was unclear. There was no effect of nutrition type on the incidence of noninfective complications in the surgical and trauma groups. Marik et al. (50) , analyzing a surgical cohort, did not observe an increase in noninfective complications with PN. Braunschweig and colleagues also did not demonstrate a treatment effect for tube feeding on noninfective complications (11). Heyland et al. (8) did not separately look at noninfective and infective complications.
Technical or nutritional support complications are more difficult to assess. The reporting of these complications was varied with some studies reporting hyperglycemia or vomiting as complications and others not including them. Six studies mentioned technical complications in only one treatment arm. There were also instances of multiple enteral tube placements when dislodged (34) . Although Braunschweig et al. (11) reported a lower There is no effect of nutrition supplementation type on mortality.
incidence of nutritional support complications with tube feeding, in the current study, only the medical group had a reduction in technical complications with EN, presumably because patients in three of the five studies were prescribed only an oral diet. All of these factors possibly contributed to the observed heterogeneity.
Diarrhea as a complication after nutritional supplementation has not been previously considered in the other metaanalysis. This study found a high incidence of diarrheal episodes with EN compared with PN, which was understandable. This effect was more demonstrable in the surgical and trauma groups.
In summary, this metaanalysis did not demonstrate a benefit of early EN over early PN with respect to mortality. A favorable effect of EN on complications rates and hospital and ICU LOS was observed, translating to a reduction of one patient with an infective complication for every 13 patients and one patient with a noninfective complication for 20 patients treated with EN. However, the status of these favorable secondary outcomes must be qualified by the presence of both heterogeneity (perhaps exacerbated by transnational differences in nutritional practices) and missing data.
The observed increase in infective complications with PN is explicable in terms of our current understanding. A higher incidence of catheter-related bloodstream infections with PN was not surprising. Bacterial translocation in the gut, postulated to play a role in infections, is thought to be prevented by EN (10) . Higher blood glucose levels with PN, as observed in 12 of 13 studies reporting blood glucose, could have also contributed to increased infections. The impact of less-than-adequate control of blood glucose on mortality and infections has been recently demonstrated in postcardiac surgery ICU patients (51) . With the more recent emphasis on tighter blood glucose control and the presence of heterogeneity and missing data (which is likely to overestimate the true effect/ intrastudy publication bias (52)), the impact of PN on infective complications may in fact be more apparent than real and closer to the null than estimated in this analysis.
Noninfective complications appear to correlate with infective complications, although in lesser magnitude (Table 4) . Although the effect of PN on infection rates was significant across the three groups, the effect of PN on noninfective complications was restricted to the medical group. The reason for this is unclear, and small numbers in the surgical and trauma groups preclude definite conclusions. Again, in both technical complications and diarrheal episodes, the number of trials was variably Ͻ50% of the poten- tial number of trials, making interpretation difficult.
The current metaanalysis specifically focuses on the issue of early nutritional support and encompasses a more homogeneous cohort of EN versus PN compared with the recently published metaanalysis that included two types of EN (11) . We excluded two studies included in Braunschweig et al.'s analysis (11) that dealt with preoperative nutrition (53) and delayed nutritional support (54) and included 18 studies not included previously. A sensitivity analysis (55) was also performed on predefined well-recognized subgroups that included medical, surgical, or trauma patients. The temptation to test other subcategories was resisted because the small numbers may lead to erroneous results and interpretations; similarly, quality scores were not derived because of the controversial nature of these assessments (56) . A more detailed analysis of complications was also undertaken in this study. The exclusion of nonEnglish articles as well as lack of correspondence to authors may have had the potential to miss studies; however, detailed assessment of publication bias as well as extensive hand-search is likely to have minimized this. The presence of heterogeneity (a feature in all nutrition metaanalysis), missing data, and the lack of blinding serve to moderate study results.
Thus, despite the expectations that early EN would be superior to early PN, no mortality effect could be demonstrated in this analysis that included over 2,000 patients. A significant reduction in complication rates with EN (despite lower caloric intake) did not translate to a reduction of mortality, albeit a small reduction in hospital LOS (1.2 days) and ICU LOS (1.4 days) was observed. Dropout rates were significantly higher with EN. Further RCTs on early nutrition are unlikely to change mortality estimates. Large multicentric studies focusing on select subgroups (ICU patients, head trauma, gastrointestinal surgery) and specific secondary outcomes (complications, hospital and ICU LOS) would illuminate our understanding of the role and mode of early nutritional support.
